


Ask a doctor about a prescription for Tobrex
Tobramycin
Tobrex is an antibiotic that works against many species of microorganisms that can infect the eye. Tobrex is intended for the treatment of external eye infections and their surroundings in adults and children over 1 year of age, caused by bacteria sensitive to its active substance - tobramycin.
Before starting to use Tobrex, discuss it with your doctor or pharmacist:
Tell your doctor or pharmacist about all medicines the patient is taking, has recently taken, or might take, as well as any medicines they plan to use. If the patient is using other eye drops or ointments, they should keep a 5-minute interval between administrations of consecutive medicines. Eye ointments should be used last.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor before using this medicine. Pregnancy Tobrex may be used during pregnancy only if it is absolutely necessary. Breastfeeding The use of Tobrex is not recommended during breastfeeding. The doctor will decide whether to continue or stop breastfeeding or continue or stop treatment, considering the benefits of breastfeeding for the child and the benefits of treatment for the mother.
Tobrex has no or negligible influence on the ability to drive and use machines. After using Tobrex, vision may be blurred for some time. Do not drive or operate machines until this symptom subsides. During the treatment of eye inflammation, wearing contact lenses is not recommended.
This medicine should always be used exactly as the doctor has told the patient. In case of doubts, consult a doctor or pharmacist. In mild or moderate diseases, a small amount (about 1.5 cm) of ointment is applied to the conjunctival sac of the infected eye(s) two or three times a day. In severe cases, a small amount (about 1.5 cm) of ointment is applied to the conjunctival sac of the infected eye(s) every 3 to 4 hours for the first two days, then two to three times a day until the infection subsides. Tobrex eye ointment can be used before bedtime, in combination with Tobrex eye drops, solution, during the day. The medicine is usually used for 7 to 10 days. The medicine should be used for as long as the doctor has prescribed.
Tobrex eye ointment can be used in children over 1 year of age in the same doses as in adults. The safety and efficacy of using the medicine in children under 1 year of age have not been established, and no data are available for such use.
In the elderly, the same dose is used as in adults.
The safety and efficacy of using Tobrex in patients with liver or kidney impairment have not been established. Method of administration Tobrex is intended exclusivelyfor use in the eye.

Method of administration
In case of overdose, excess medicine can be rinsed from the eye with lukewarm water. No side effects are expected. Do not administer additional ointment to the eye. The next dose should be given at the usual time.
If the patient forgets to use Tobrex, they should continue treatment by administering the next dose according to the dosing schedule. If it is almost time for the next dose, skip the missed dose and continue treatment according to the prescribed dosing schedule. Do not use a double doseto make up for the missed dose. If the patient is using other eye drops or ointments, they should keep a 5-minute interval between administrations of consecutive medicines. Eye ointments should be used last.
Like all medicines, Tobrex can cause side effects, although not everybody gets them. If the patient experiences allergic reactions, including rash, swelling of the face, lips, tongue, and/or throat, which may cause difficulty breathing or swallowing, or other serious side effects, they should stop using Tobrex and contact a doctor or the Emergency Department of the nearest hospital immediately.The following side effects have been observed during the use of Tobrex: Common side effects (may affect up to 1 in 10 people)Eye symptoms: feeling of discomfort in the eye, eye redness. Uncommon side effects (may affect up to 1 in 100 people)Eye symptoms: inflammation of the eye surface, corneal damage, vision disturbances, blurred vision, eyelid redness, eye and eyelid swelling, eye pain, dry eye, eye discharge, eye itching, increased tear production. General symptoms: allergy (hypersensitivity), headache, hives, skin inflammation, reduced eyelash growth or eyelash loss, skin depigmentation, itching, and dry skin. Frequency not known (frequency cannot be estimated from the available data)Eye symptoms: eye allergy, eye irritation, eyelid itching. General symptoms: severe allergic reactions, severe skin reactions (Stevens-Johnson syndrome, erythema multiforme), rash.
Side effects can be reported directly to the Department for Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products Al. Jerozolimskie 181 C 02-222 Warsaw Tel.: +48 22 49 21 301 Fax: +48 22 49 21 309 Website: https://smz.ezdrowie.gov.pl By reporting side effects, more information can be collected on the safety of this medicine.
To prevent infection of the ointment, the tube should be discarded 4 weeks after first opening.In the space marked below, write the date of opening the tube. Date of first opening: ……………. The medicine should be kept out of the sight and reach of children. Store below 25°C. Do not store in the refrigerator. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
1 tube containing 3.5 g of ointment, placed in a cardboard box. For more detailed information, consult the marketing authorization holder or parallel importer.
Novartis Pharma NV, Medialaan 40, B-1800 Vilvoorde, Belgium
ALCON CUSI S.A., Camil Fabra 58, 08320 El Masnou, Barcelona, Spain SA ALCON-COUVREUR NV, Rijksweg 14, B-2870 Puurs, Belgium
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź Permit number in Belgium, the country of export: BE125115
[Information about the trademark]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Tobrex – subject to medical assessment and local rules.